Page 91 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

2 Minute Medicine Rewind September 4, 2023 | 2 Minute Medicine

Direct Dispensation of Prenatal Supplements With Iron and Anemia Among Pregnant People 1. In an underserved community, providing free iron-containing prenatal vitamins improved hematocrit, reduced the prevalence of anemia, and reduced the need for postpartum blood transfusions. Evidence rating level: 2 (Good) Maternal anemia during pregnancy is associated with a greater need for postpartum blood ....

United States , South Africa , Novgorodskaya Oblast , Canadian Community Health , Parkland Health , Child Health Cohort , Indigenous Canadians , Canadian Community Health Survey , Indigenous Females , First Nations , Global Burden , Tongji Maternal , Chronic Disease , Indigenous Health , Public Health , Weekly Rewinds ,

Dr Qin on Areas of Active and Future Investigation in NSCLC

Angel Qin, MD, discusses several areas of active investigation in non–small cell lung cancer, and highlights questions necessitating future research in this disease space. ....

United States , Angel Qin , Rogel Cancer Center , University Of Michigan Health , Medical Oncology , Internal Medicine , Michigan Health , Lung Cancer , University Of Michigan ,

Vitamin D3 supplementation may improve relapse-free survival for certain digestive tract cancers

1. This post-hoc analysis of the AMATERASU randomized clinical trial found that, for digestive tract cancer patients with positive p53-immunoreactivity, 2000 IU/day vitamin D3 supplementation resulted in significantly improved relapse-free survival at 5 years. Evidence Rating Level: 1 (Excellent) Recent meta-analyses of randomized clinical trials have found that daily vitamin D3 supplementation benefited cancer mortality. ....

Rating Level , Gastric Cancer , Vitamin D ,

Lisocabtagene maraleucel may induce remission in relapsed chronic lymphocytic leukemia (CLL)

1. Complete response or remission was reported in 18% of patients who received a single liso-cel infusion. 2. Nearly 10% of fatalities were thought to be due to liso-cel related complications. Evidence Rating Level: 1 (Excellent) Study Rundown: There exist limited options for patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic ....

United States , Rating Level , First Line Venetoclax Combinations , Chronic Lymphocytic , Between Jan , Chronic Lymphocytic Leukemia , Chronic Lymphocytic Leukemia Cll , Hematologic Cancer , Hematologic Malignancy , Hematology Oncology , Lisocabtagene Maraleucel , Small Lymphocytic Lymphoma , Chronic Disease ,